JP and TT/SR coupling and shRNA-mediated suppression of JP in mammalian skeletal muscle. (A) JP is a unique protein that spans the junctional gap between TT invagination of cell surface membrane and terminal cisternae of SR in muscle cells. DHPR is represented in blue, RyR is shown in green, store-operated Ca2+ channel is shown in yellow, and JP is in red. (B) The functional motifs of JP are divided into three domains: a TM sequence inserted into the SR membrane, repeated “MORN” sequences that adhere to the TT membrane, and an α-helical-rich structure in the middle. The listed nucleotide sequence represents the siRNA target. (C) Western blot of JP1 and JP2 expression in siRNA oligonucleotide transfected C2C12 myotubes performed at day 5 after myotube differentiation, providing over 95% transfection efficiency. Controls represent muscles transfected with a scramble siRNA probe. p-values of ≤0.01 were considered as significant (same criteria in following figures). Normalized protein levels with actin show that shRNAs significantly knock down both JP1 and JP2 (lower panel, n = 5–8, p = 2.11529E-7 and 0.00358, respectively) but do not affect the expression of RyR1, DHPR, SERCA2, and CSQ in C2C12 myotubes. (D) Immunostaining of C2C12 myotubes transfected with the pU6-EGFP (with luciferase shRNA as control) and pU6-EGFP (shRNA), providing ∼30% transfection efficiency. Transfected cells are labeled with GFP, and red fluorescence represents staining of JP1 and JP2 with specific antibodies. Any yellow fluorescence in RNAi panels likely results from the presence of overlapping nontransfected myotubes in the cell layers. These pictures were representative of 16 experiments.